Malignant Lymphoma:
Author:
Affiliation:
1. Medical student, Nihon University School of Medicine
2. Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine
Publisher
The Nihon University Medical Association
Subject
Applied Mathematics,General Mathematics
Link
https://www.jstage.jst.go.jp/article/numa/81/2/81_83/_pdf
Reference28 articles.
1. Ledford H. The poisonous history of chemotherapy Nature. 2020; 585: 346–347.
2. Alfred G, S. PF. The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides. Science 1946; 103: 409–436.
3. Johnson IS, Armstrong JG, Gorman M, et al. The Vinca Alkaloids: A New Class of Oncolytic Agents. Cancer Res 1963; 23: 1390–1427.
4. DeVita VT, Canellos GP, Chabner B, et al. Advanced Diffuse Histiocytic Lymphoma, a Potentially Curable Disease. Results with Combination Chemotherapy. Lancet 1975; 305: 248–250.
5. Cabanillas F, Rodriguez V, Freireich EJ. Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens. Med Pediatr Oncol 1978; 4: 321–331.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3